Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Case 3-2001: unilateral visual loss

S Lessell

    The New England Journal of Medicine
    |June 16, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Autosomal dominant hereditary optic neuropathy (ADOA): a review of the genetics and clinical manifestations of ADOA and ADOA+.

    Seminars in ophthalmology·2013
    Same author

    Monocular elevator paresis in neurofibromatosis type 2.

    Neurology·2001
    Same author

    Acute idiopathic blind spot enlargement syndrome: a review of 27 new cases.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2001
    Same author

    Concordance of bilateral temporal artery biopsy in giant cell arteritis.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2000
    Same author

    Posterior subcapsular cataract in Degos disease.

    American journal of ophthalmology·2000
    Same author

    Endothelial cell loss in irradiated optic nerves.

    Ophthalmology·2000
    Same journal

    Advances in Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

    The New England journal of medicine·2026
    Same journal

    Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

    The New England journal of medicine·2026
    See all related articles